Publicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (8)

2023

  1. Modulating T Cell Responses by Targeting CD3

    Cancers, Vol. 15, Núm. 4

2022

  1. A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 413-425

  2. IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

    Molecular Cancer, Vol. 21, Núm. 1

  3. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

    Biomedicines, Vol. 10, Núm. 8

2020

  1. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204

2019

  1. ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

    Molecular Therapy, Vol. 27, Núm. 11, pp. 1878-1891

2018

  1. Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors

    OncoImmunology, Vol. 7, Núm. 8

2016

  1. Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy

    Biomaterials, Vol. 91, pp. 73-80